sTREM-1 is a specific biomarker of TREM-1 pathway activation-Reference-Cited by-同舟云学术

sTREM-1 is a specific biomarker of TREM-1 pathway activation

Published:2021-07-19 Issue:8 Volume:18 Page:2054-2056
ISSN:1672-7681
Container-title:Cellular & Molecular Immunology
language:en
Short-container-title:Cell Mol Immunol

Author:

Jolly Lucie,Carrasco Kévin,Salcedo-Magguilli Margarita,Garaud Jean-Jacques,Lambden Simon^ORCID,van der Poll Tom^ORCID,Mebazaa Alexandre,Laterre Pierre-François,Gibot Sebastien,Boufenzer Amir,Derive Marc

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/s41423-021-00733-5.pdf

Reference7 articles.

1. Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000;164:4991–5.

2. Jolly L, Carrasco K, Derive M, Lemarié J, Boufenzer A, Gibot S. Targeted endothelial gene deletion of triggering receptor expressed on myeloid cells-1 protects mice during septic shock. Cardiovasc Res. 2018;114:907–18.

3. Boufenzer A, Carrasco K, Jolly L, Brustolin B, Di-Pillo E, Derive M, et al. Potentiation of NETs release is novel characteristic of TREM-1 activation and the pharmacological inhibition of TREM-1 could prevent from the deleterious consequences of NETs release in sepsis. Cell Mol Immunol. 2021;18:452–60.

4. François B, Wittebole X, Ferrer R, Mira J-P, Dugernier T, Gibot S, et al. Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial. Intensive Care Med. 2020;46:1425–37.

5. Weiss G, Lai C, Fife ME, Grabiec AM, Tildy B, Snelgrove RJ, et al. Reversal of TREM-1 ectodomain shedding and improved bacterial clearance by intranasal metalloproteinase inhibitors. Mucosal Immunol. 2017;10:1021–30.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PGLYRP1 protein as a novel mediator of cellular dialogue in neuroinflammation;Neural Regeneration Research;2024-07-10

2. A distinct inflammatory and fibrogenic cytokine milieu in oral submucous fibrosis;Frontiers of Oral and Maxillofacial Medicine;2024-06

3. Hospital Acquired Sepsis, Disease Prevalence, and Recent Advances in Sepsis Mitigation;Pathogens;2024-05-30

4. Dynamic Changes in Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Sepsis with Respect to Antibiotic Susceptibility;Infection and Drug Resistance;2024-05

5. Soluble triggering receptor expressed on myeloid cells: a marker for diagnosis of spontaneous bacterial peritonitis;Tanta Medical Journal;2024-04